Synchrony Financial (SYF) reported its fourth-quarter 2024 earnings, with a GAAP EPS of $1.91, missing the $1.93 estimate. The company's revenue reached $3.8 billion, falling short of expectations by $30 million. Additionally, Synchrony noted a provision for credit losses of $1.56 billion, higher than the estimated $1.52 billion, and a net charge-off rate of 6.45%, up from 6.06% in the previous quarter and 5.58% a year ago. Meanwhile, Kimberly-Clark (KMB) announced an adjusted EPS of $1.50, slightly below the $1.51 estimate, while its revenue of $4.93 billion surpassed the $4.86 billion estimate. The company experienced a 0.85% year-over-year decline in revenue. Danaher (DHR) reported an adjusted EPS of $2.14, missing the $2.16 estimate, but its revenue of $6.54 billion exceeded the $6.39 billion estimate, marking a 2% year-over-year increase. The company’s biotech revenue was $1.87 billion, also slightly below expectations. Danaher’s net earnings for the quarter were $1.1 billion, with operating cash flow of $2.0 billion.